Chair Naiad Foundation in Breast Engineering
Millions of women worldwide are affected by breast cancer. For many patients, the impact does not end after treatment. Breast reconstruction often plays a crucial role in recovery, well-being and quality of life. Nevertheless, current reconstruction options remain limited. Regenerative medicine and tissue engineering offer the prospect of more sustainable, natural and patient-specific solutions. The Naiad Foundation Chair in Breast Engineering aims to contribute to a future in which innovative science offers women new opportunities for recovery and quality of life.
Objectives
The chair focuses on the development of new therapeutic strategies for the reconstruction of damaged or removed breast tissue. In doing so, the team is investigating how isolated human cells can be used to repair, regenerate or even functionally improve tissues.
The research includes, among other things:
- Cell therapy and regenerative medicine: Researchers are studying how human cells from adipose tissue and other tissues can be used to develop new therapies for tissue repair and regeneration.
- Biomaterials and smart hydrogels: New biomaterials are being developed to support the survival, growth and functionality of transplanted cells.
- 3D bioprinting: The chair supports research into advanced bioprinting techniques that enable the construction of complex, functional tissue structures.
- Personalised reconstruction: Through innovative techniques, the research aims to contribute to reconstructive solutions that are better tailored to the body and the needs of individual patients.
Donor
Period
2026- today
Supervisor
He is internationally recognised for his expertise in reconstructive surgery, breast reconstruction and regenerative medicine. Within the Chair, he will act as a supervisor.
Under his leadership, the TROP Lab (Tissue Regeneration and Organ Printing Laboratory) is working on innovative applications of cells, biomaterials and biofabrication for regenerative medicine.